GE HealthCare Technologies (NASDAQ:GEHC) Upgraded to Neutral at UBS Group
UBS Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a sell rating to a neutral rating in a report released on Monday morning, MarketBeat reports. UBS Group currently has $73.00 target price on the stock, down from their previous target price of $74.00. Several other equities research analysts have also issued […]
UBS Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a sell rating to a neutral rating in a report released on Monday morning, MarketBeat reports. UBS Group currently has $73.00 target price on the stock, down from their previous target price of $74.00. Several other equities research analysts have also issued […]
